Owlstone Ltd

Industry · 9 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Unknown	Early Liver Disease Breath Detection Liver Fibrosis, NASH, Liver Diseases	—	2024-05-21
Recruiting	DELIVER Study in a Population With Clinical Suspicion of Liver Cirrhosis Cirrhosis, Liver	—	2024-05-10
Unknown	Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transp Invasive Aspergillosis	—	2023-12-12
Recruiting	Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2) Lung Cancer	Phase 2	2023-10-05
Completed	Safety and Dose Ranging Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution) Lung Cancer	Phase 1	2021-07-06
Completed	Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study Covid19	—	2020-09-30
Completed	Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols COVID	—	2020-07-30
Completed	PAN-study: Pan-Cancer Early Detection Study (PAN) Gastric Cancer, Esophageal Cancer, Liver Cancer	—	2018-09-26
Completed	Lung Cancer Indicator Detection Lung Cancer	N/A	2015-10-07